The mass of pancreatic β-cells is maintained throughout lifetime to control blood glucose levels. Although the major mechanism of the maintenance of β-cell mass after birth is thought to be selfreplication of pre-existing β-cells, it is possible that pancreatic β-cells are also generated from non-β-cells. Here, we address this issue by using the inducible Cre/loxP system to trace β-cells. We generated Ins2-CreERT2/R26R-YFP double knock-in mice, in which pancreatic β-cells can be labeled specifically and permanently upon injection of the synthetic estrogen analog tamoxifien, and then traced the β-cells by pulse and chase experiment in several different conditions. When β-cells were labeled in adults under physiological and untreated conditions, the frequency of the labeling (labeling index) was not altered significantly throughout the 12-month experimental period. In addition, the labeling index was not changed after ablation of β-cells by streptozotocin treatment. However, when tamoxifen was injected to pregnant mothers just before they gave birth, the labeling index in the neonates was decreased significantly around weaning, suggesting that β-cells are generated from non-β-cells. These results indicate that various mechanisms are involved in the maintenance of β-cells after birth, and that the present system using knock-in mice is useful for investigation of β-cell fate.
Pancreatic β-cells produce and secrete insulin, which is the only hormone that lowers blood glucose levels. The mass of the β-cells is not static but rather dynamic throughout lifetime (9, 19) . The number of pancreatic β-cells increases in response to systemic insulin demand in obesity (18) and pregnancy (29) , as well as in the neonatal period (17) . It has been thought that β-cells are constantly replenished even under normal conditions (turnover) (9, 19) . In general, adult tissues and organs are thought to be maintained by the stem cell system. The primary role of adult (tissue-specific) stem cells is to maintain and repair the tissue in which they reside. Although such stem cells have been found in several tissues including neurons (32) , small intestine (5) , and blood (15) , both the existence and the nature of stem or progenitor cells in adult pancreas are yet to be established. By using genetic cell lineage tracing, Dor et al. demonstrated that adult pancreatic β-cells in mice GGTCCTCCACTTCA-3', and reverse for CreERT2: 5'-CAGCATTGCTGTCACTTGGT-3'). The amplicons were 362 bp for the wild type allele and 512 bp for the targeted allele ( Fig. 1A and B) . Ins2-CreERT2 knock-in mice were crossed with R26R-YFP mice (provided by F. Costantini, Columbia University, New York) (30) to generate Ins2-CreERT2/R26R-YFP mice for tracing pancreatic β-cells.
Labeling β-cells by tamoxifen injection.
For lineage tracing in adult pancreas, Ins2-CreERT2/R26R-YFP mice of 6 weeks of age were injected intraperitoneally with tamoxifen (Sigma, St. Louis, MO) five times (6 mg/head for the first time and 4 mg/head for the remaining) within two weeks. For tracing in neonates, pregnant mothers of Ins2-CreERT2/R26R-YFP mice were injected intraperitoneally with a single dose of 6 mg/30 g body weight of 4-hydroxytamoxifen (Sigma) on the day before they gave birth.
Streptozotocin treatment. For tracing β-cells after a severe injury, Ins2-CreERT2/R26R-YFP mice were injected intraperitoneally with streptozotocin (STZ) (Sigma) at 100 mg/kg body weight 10 days after tamoxifen treatment as described above. Mice with blood glucose concentration above 300 mg/dL were used for the study.
Immunohistochemistry. Pancreata removed from the mice were fixed in 4% paraformaldehyde. Frozen sections were stained with antibodies against insulin (Zymed, San Francisco, CA) (1 : 100), Cre (Novagen, Madison, WI) (1 : 10,000), GFP (Molecular Probes, Eugene, OR) (1 : 200), and Ki67 (Dako Japan, Tokyo, Japan) (1 : 500). Secondary antibodies conjugated with Alexa Fluor 488-or 546 (1 : 400) (Molecular Probes) were used for detection. Nuclei were visualized by DAPI (Dojindo, Kumamoto, Japan). Because YFP is one of the emission variants of GFP in which only four amino acids are substituted from GFP, antibodies against GFP can recognize this protein (20) . The stained sections were observed with BZ9000 microscope (Keyence, Osaka, Japan). The frequency of the labeling (labeling index) of the pancreatic β-cells was calculated by dividing the number of YFP-positive cells by the number of insulin-positive cells. For measurement of β-cell mass, we first measured percent area of β-cells in the pancreas from five distinct sections of each mouse pancreas. The β-cell mass was then estimated by multiplying the β-cell area by the pancreas weight of corresponding animals. All data are means of the are maintained predominantly by self-replication of pre-existing β-cells (6) . Furthermore, another study using a DNA analog-based lineage-tracing technique showed that unlike gastrointestinal and skin epithelia, specialized progenitors do not contribute to adult β-cell mass, even during acute β-cell regeneration (33) . Instead, adult β-cells exhibit equal proliferation potential, and expand from a vast and uniform pool of mature β-cells (3) . These findings support the notion that the mass of pancreatic β-cells is maintained primarily by self-replication of pre-existing β-cells. On the other hand, there are many studies suggesting generation of pancreatic β-cells from non-β-cells (Ref. 21 for review). Importantly, Xu et al. made use of a unique model of tissue damage and found that cells expressing Ngn3, which represent progenitors for endocrine cells during embryogenesis, reappeared in adult mice following injury and gave rise to new β-cells (36) . This study provides evidence that facultative β-cell progenitors exist, although definitive identification of the cell type having progenitor property remains elusive. Extensive analysis of the formation of new pancreatic β-cells is required to elucidate the mechanisms of the maintenance of β-cell mass.
In the present study, we newly generated a knockin mouse model, in which the endogenous mouse insulin 2 gene is replaced with a gene of Crerecombinase and modified estrogen receptor fusion protein (CreERT2). By crossbreeding these mice with a reporter strain expressing yellow fluorescent protein (YFP) by Cre-mediated loxP recombination (R26R-YFP) (30), we established a system for tracing pancreatic β-cells upon tamoxifen injection. We analyzed the fate of pancreatic β-cells in the Ins2-CreERT2/R26R-YFP double knock-in mice in three different settings. Our data indicate that new β-cells are generated from non-β-cells after birth.
MATERIALS AND METHODS

Generation of Ins2-CreERT2/R26R-YFP mice.
All animal experiments were approved by the Animal Research Committee of Kobe University Graduate School of Medicine. Ins2-CreERT2 knock-in mice were generated by replacing the mouse insulin 2 gene with a CreERT2 cassette, which was inserted into the ATG site of the gene located in exon 2, by homologous recombination (Fig. 1A) . Genotyping of Ins2-CreERT2 knock-in mice was performed by PCR with primers for mouse insulin 2 and CreERT2 (forward for both genotypes: 5'-CCCTAAGTGATC CGCTACAA-3', reverse for wild type: 5'-CTTGTG recombinase driven by insulin promoter, expression of Cre-recombinase in the Ins2-CreERT2 knock-in mice perfectly reproduces insulin expression and no position effect is caused in the mice. We confirmed that body weight and casual blood glucose levels of the homozygous mice were identical to those of the heterozygous and wild-type mice ( Fig. 1C and D) . Expression of Cre-recombinase was detected only in insulin-expressing β-cells (Fig. 1E ). We then crossbred the Ins2-CreERT2 knock-in mice with R26R-YFP mice (30) to generate Ins2-CreERT2/R26R-YFP double knock-in mice ( Fig. 2A) . Upon injection of tamoxifen as described in MATERIALS AND METHODS, expression of YFP was detected exclusively in insulin-expressing β-cells (Fig. 2B ). These results demonstrate that Ins2-CreERT2/R26R-YFP double knock-in mice work well for tracing pancreatic β-cell fate.
results from five mice.
Statistical analysis.
Values are expressed as means ± S.E. The significance of difference between test groups was evaluated by use of multiple analysis of Tukey-Kramer's test. P < 0.05 was considered significant.
RESULTS
Generation of Ins2-CreERT2/R26R-YFP double knockin mice
We first generated Ins2-CreERT2 knock-in mice, in which a fusion protein containing Cre-recombinase and modified estrogen receptor is replaced with mouse insulin 2 gene (Fig. 1A) . Genotypes of the mice were determined by genomic PCR (Fig. 1B) . Unlike conventional transgenic mice expressing Cre- weeks of age. Three days after the last injection (pulse), pancreata of these mice were dissected and subjected to immunostaining for YFP and insulin to determine labeling index. We found that 25.8 ± 3.75% of insulin-positive cells were labeled with YFP ( Fig. 3B and C) . The labeling index was not changed significantly throughout the 12-month ex-
Tracing pancreatic β-cells with aging under normal condition
Using Ins2-CreERT2/R26R-YFP double knock-in mice, we chased pancreatic β-cells in several settings. Firstly, we investigated the β-cells in adult under normal condition (Fig. 3A) . We injected tamoxifen five times to the mice for two weeks starting at 6 perimental period (Fig. 3B and C) . This result is consistent with the previous finding by Dor et al. (6) . Our data support the notion that the major mechanism of the maintenance of adult pancreatic β-cells may be self-replication rather than neogenesis from stem/progenitors under normal condition, as reported previously (6, 10) .
Tracing pancreatic β-cells after β-cell ablation
Although β-cell mass is maintained by self-replication under normal condition, it has been suggested that neogenesis from stem or progenitor cells could contribute to generation of new β-cells after injury (22) . The β-cell toxin streptozotocin (STZ) is known to cause rapid and severe β-cell damage. In some studies, it has been found that insulin-positive cells reappear after the loss of pancreatic β-cells by STZ treatment (8, 13) . Therefore, we examined pancreatic β-cell fate after STZ treatment to investigate whether β-cells might be generated from non-β-cells (Fig. 4A) . Pancreatic β-cells of Ins2-CreERT2/R26R-YFP double knock-in mice were labeled by tamoxifen injection 10 days before STZ treatment (100 mg/kg, i.p.).
This dose of STZ caused a moderate loss of pancreatic β-cells (Fig. 4B) . We traced the β-cells for up to 3 months after STZ treatment. The labeling index of these β-cells was unchanged throughout the experiment (Fig. 4C) , indicating that neogenesis of β-cells from non-β-cells did not occur under the conditions used. While we failed to detect replenishment of β-cells after treatment of STZ, further examination using other models of β-cell regeneration are required to clarify whether neogenesis participates in regeneration of pancreatic β-cells.
Tracing pancreatic β-cells in neonate
The mass of pancreatic β-cells increases rapidly within a month after birth (7) . It has been thought that the increase in β-cell mass depends largely on replication of pre-existing β-cells during this time (9, 17) . If this is the case, the labeling index in Ins2-CreERT2/R26R-YFP double knock-in mice should be unchanged in this period. We injected 4-hydorxytamoxifen to pregnant mothers of the mice one day before they gave birth (Fig. 5A) . The frequency of the labeling of pancreatic β-cells of new born mice beling index of pancreatic β-cells in the mice was unchanged from P0 to P14 (Fig. 5F ). However, the index significantly decreased at P28 (Fig. 5F ), suggesting the generation of new β-cells by other mechanisms than replication of pre-existing β-cells in this period.
DISCUSSION
Several studies have shown that adult mouse pan-(P0) was 28.0 ± 0.95% of total β-cells. We confirmed that the pancreas weight of the mice was increased (Fig. 5B) . The mass of β-cells was also increased, especially between postnatal day 14 (P14) and P28 (Fig. 5C ). This is consistent with a previous study in rats showing that a significant increase in β-cell mass was seen after P20 (25) . Proliferating cell marker Ki67-positive cells could readily be detected (Fig. 5D) , suggesting that massive replication of the β-cells occurs during this period (Fig. 5E ). The la- 
REFERENCES
creas does not require progenitors for β-cells (6, 10, 33) . In addition, the size of the pancreas depends on the number of embryonic progenitor cells, indicating that there is no contribution of postnatal progenitors to growth of the pancreas (31) . Furthermore, a recent paper demonstrated that pancreatic duct cells, which have been thought to contain the progenitor pool, do not give rise to β-cells after birth (26) . These studies strongly suggest that adult pancreatic β-cells are maintained by self-replication of pre-existing β-cells, and that there be no stem or progenitor cells of β-cells in the adult pancreas. However, in the adult pancreas, the generation of β-cells from non-β-cells under certain conditions is also suggested (11, 12, 14, 28, 35, 36) . For example, Hao et al. have shown that non-endocrine epithelial cells of the adult human pancreas differentiate into β-cells when transplanted under the renal capsule (14) . In vitro generation of β-cells from non-β-cells has also been reported by many laboratories (1, 2, 20, 24, 27) . These results clearly indicate that there are cells having potential to generate β-cells in the adult pancreas. Moreover, Xu et al. reported that progenitors for β-cells reside in adult pancreas and can be activated by injury to generate all islet cell types including β-cells in vivo (36) . We also have shown that pancreatic β-cells of transgenic mice expressing a dominant-negative form of Kir6.2, a subunit of the β-cell-type ATP-sensitive K + channel, were spontaneously regenerated from Dolichos biflorus agglutinin-labeled cells that appeared within the pancreatic islets (23). Inada et al. reported that carbonic anhydrase II-positive cells within the pancreas act as progenitors that give rise to new islets (16) . Very recent papers indicated that pancreatic β-cells can be generated from α-cells under conditions of severe ablation of β-cells (4, 34) . Considering these findings together, mechanisms of generation of new pancreatic β-cells other than self-replication of pre-existing β-cells may well operate in adult pancreas. Indeed, we have shown here that labeling index of pancreatic β-cells was decreased significantly from P14 to P28 (Fig. 5) , the period during which the β-cell mass was markedly increased, indicating that new β-cells are generated by both self-replication of pre-existing β-cells and neogenesis from stem or progenitor cells. As this period corresponds to that of weaning, alterations in nutritional status may be related to the phenomenon. Further investigation of the neogensis of pancreatic β-cells occurring around weaning is required to elucidate the fate of β-cells in the postnatal period.
